Ovarian cancer: identifying and managing familial and genetic risk
Project report
Slade, E., Berg, L., Dworzynski, K., Manchanda, R., Barber, V., Bowen, R., Brentnall, A., Cameron, A., Davies, D., Davies, M., Evans, D., Hayward, J., McCluggage, W., Miles, T., Monahan, K., Moses, D., Robb, F., Rosenthal, A., Side, L., Stanford, J., Stordal, B. and Tripathi, V. 2024. Ovarian cancer: identifying and managing familial and genetic risk. National Institute for Health and Care Excellence.
Type | Project report |
---|---|
Title | Ovarian cancer: identifying and managing familial and genetic risk |
Authors | Slade, E., Berg, L., Dworzynski, K., Manchanda, R., Barber, V., Bowen, R., Brentnall, A., Cameron, A., Davies, D., Davies, M., Evans, D., Hayward, J., McCluggage, W., Miles, T., Monahan, K., Moses, D., Robb, F., Rosenthal, A., Side, L., Stanford, J., Stordal, B. and Tripathi, V. |
Abstract | This guideline covers assessing the familial and genetic risk of having a pathogenic variant associated with ovarian cancer in adults. In women, trans men and non-binary people with female reproductive organs (ovaries, fallopian tubes and/or a uterus), having a pathogenic variant increases the risk of developing ovarian cancer (familial ovarian cancer). As well as risk assessment, this guideline covers risk management and decision-making support for people born with female reproductive organs who have, or are at risk of having, a pathogenic variant associated with ovarian cancer. Men, trans women and non-binary people born with male reproductive organs cannot develop ovarian cancer, but if they have a pathogenic variant associated with ovarian cancer, they can pass the variant on to their children, and may be at risk of developing other cancers. This guideline covers risk assessment, but it does not cover managing risk or decision-making support for people born with male reproductive organs. NICE has also produced a guideline on the recognition and initial management of ovarian cancer. |
Sustainable Development Goals | 3 Good health and well-being |
Middlesex University Theme | Health & Wellbeing |
Research Group | Biomarkers for Cancer group |
Publisher | National Institute for Health and Care Excellence |
Publication dates | |
21 Mar 2024 | |
Publication process dates | |
Accepted | 21 Mar 2024 |
Deposited | 10 May 2024 |
Output status | Published |
Additional information | NICE guideline [NG241] |
Web address (URL) | https://www.nice.org.uk/guidance/NG241 |
Language | English |
https://repository.mdx.ac.uk/item/138622
35
total views0
total downloads3
views this month0
downloads this month